glp 1 microdose EllieMD | THE GLP-1 MICRODOSING PROGRAM
Description
As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)
In earlier studies, retatrutide reduced liver fat by more than 80% in people with metabolic fatty liver disease, with most participants no longer meeting diagnostic thresholds
The program is designed to expand access to a high-demand class of medications that have been financially out of reach for many.
FRIDAY, Feb
Does GLP-1 cause eye problems
